Z12.31, Encounter for screening mammogram for malignant neoplasm of breast, is the primary diagnosis code assigned for a screening mammogram. If the mammogram is diagnostic, the ICD-10-CM code assigned is the reason the diagnostic mammogram was performed.
Z12.31 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Encntr screen mammogram for malignant neoplasm of breast. The 2021 edition of ICD-10-CM Z12.31 became effective on October 1, 2020.
If the patient has a personal history of breast cancer, has completed active treatment and is back to annual mammographic screening, report V76.11. No additional personal history code is required as V76.11 inherently covers this diagnosis; however, you may report a personal history of breast cancer (V10.3) as a secondary code if you like.
Personal history of biopsy-proven benign breast disease. Report code V76.12 (Screening for malignant neoplasms, other screening mammogram) for all other screening mammography. If the patient has a personal history of breast cancer, has completed active treatment and is back to annual mammographic screening, report V76.11.
Z12. 31, Encounter for screening mammogram for malignant neoplasm of breast, is the primary diagnosis code assigned for a screening mammogram. If the mammogram is diagnostic, the ICD-10-CM code assigned is the reason the diagnostic mammogram was performed.
Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is reported for screening mammograms while Z12. 39 (Encounter for other screening for malignant neoplasm of breast) has been established for reporting screening studies for breast cancer outside the scope of mammograms.
8 for Other abnormal and inconclusive findings on diagnostic imaging of breast is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
ICD-10 code Z12. 39 for Encounter for other screening for malignant neoplasm of breast is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
The proper diagnosis code to report would be Z12. 31, Encounter for screening mammogram for malignant neoplasm of breast. The Medicare deductible and co-pay/coinsurance are waived for this service.
31: Encounter for screening mammogram for malignant neoplasm of breast.
ICD-10 code N64. 4 for Mastodynia is a medical classification as listed by WHO under the range - Diseases of the genitourinary system .
ICD-10-CM Code for Unspecified lump in the right breast, upper outer quadrant N63. 11.
39 (Encounter for other screening for malignant neoplasm of breast). Z12. 39 is the correct code to use when employing any other breast cancer screening technique (besides mammogram) and is generally used with breast MRIs.
These codes are being replaced by the following CPT codes: • 77067 - “screening mammography, bilateral (2-view study of each breast), including CAD when performed” • 77066 - “diagnostic mammography, including (CAD) when performed; bilateral” and • 77065 - “diagnostic mammography, including CAD when performed; ...
A screening colonoscopy should be reported with the following International Classification of Diseases, 10th edition (ICD-10) codes: Z12. 11: Encounter for screening for malignant neoplasm of the colon.
Z12.11. Encounter for screening for malignant neoplasm of colon.
39 (Encounter for other screening for malignant neoplasm of breast). Z12. 39 is the correct code to use when employing any other breast cancer screening technique (besides mammogram) and is generally used with breast MRIs.
Encounter for screening for malignant neoplasms Screening is the testing for disease or disease precursors in asymptomatic individuals so that early detection and treatment can be provided for those who test positive for the disease.
These codes are being replaced by the following CPT codes: • 77067 - “screening mammography, bilateral (2-view study of each breast), including CAD when performed” • 77066 - “diagnostic mammography, including (CAD) when performed; bilateral” and • 77065 - “diagnostic mammography, including CAD when performed; ...
77067, Screening mammography, bilateral (two-view study of each breast), including CAD when performed.
Report code V76.12 (Screening for malignant neoplasms, other screening mammogram) for all other screening mammography. If the patient has a personal history of breast cancer, has completed active treatment and is back to annual mammographic screening, report V76.11.
Diagnostic Mammography: Diagnostic mammography includes additional x-ray views of each breast, taken from different angles and if performed digitally, may be manipulated, enlarged, or enhanced for better visualization of the abnormality found during screening mammography.
Screening mammography is recommended for women age 40 and older every one to two years and younger than 40 years of age when the patient has increased risk factors for breast cancer.
In general, screening mammograms are not recommended for women under 40 years of age, in part because breast tissue tends to be more dense in younger women, making mammograms as a screening tool less effective.
Screening Mammography: Screenings are performed on otherwise healthy individuals to look for cancer or precursors to cancer of the breasts.
As a screening mammogram is inherently bilateral in nature, report modifier -52 when screening mammogram is performed on a patient with a history of mastectomy where only one breast is imaged.
Analog or conventional mammography is when the radiologist takes an image and prints it on film for the radiologist to review on a light box.
An ABN may be used for services which are likely to be non-covered, whether for medical necessity or for other reasons. Refer to CMS Publication 100-04, Medicare Claims Processing Manual, Chapter 30, for complete instructions.
The Centers for Medicare & Medicaid Services (CMS), the federal agency responsible for administration of the Medicare, Medicaid and the State Children's Health Insurance Programs, contracts with certain organizations to assist in the administration of the Medicare program. Medicare contractors are required to develop and disseminate Articles. CMS believes that the Internet is an effective method to share Articles that Medicare contractors develop. While every effort has been made to provide accurate and complete information, CMS does not guarantee that there are no errors in the information displayed on this web site. THE UNITED STATES GOVERNMENT AND ITS EMPLOYEES ARE NOT LIABLE FOR ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION, PRODUCT, OR PROCESSES DISCLOSED HEREIN. Neither the United States Government nor its employees represent that use of such information, product, or processes will not infringe on privately owned rights. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information, product, or process.
Local Coverage Articles are a type of educational document published by the Medicare Administrative Contractors (MACs). Articles often contain coding or other guidelines that are related to a Local Coverage Determination (LCD).
Section 1833 (e) prohibits Medicare payment for any claim which lacks the necessary information to process the claim.
Effective from April 1, 2010, non-covered services should be billed with modifier –GA, -GX, -GY, or –GZ, as appropriate.
Modifier GX (“Notice of Liability Issued, Voluntary Under Payer Policy”) should be used when the beneficiary has signed an ABN, and a denial is anticipated based on provisions other than medical necessity, such as statutory exclusions of coverage or technical issues. An ABN is not required for these denials, but if non-covered services are reported with modifier GX, will automatically be denied services.
CPT is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. AMA warrants that due to the nature of CPT, it does not manipulate or process dates, therefore there is no Year 2000 issue with CPT. AMA disclaims responsibility for any errors in CPT that may arise as a result of CPT being used in conjunction with any software and/or hardware system that is not Year 2000 compliant. No fee schedules, basic unit, relative values or related listings are included in CPT. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this file/product is with CMS and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon no upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.
As shown in Table C, codes 77046 and 77047 are reported for breast MRI without contrast.
Screening mammography is performed for a person without signs or symptoms of breast disease.
50 – Bilateral procedure. This modifier is used to bill bilateral procedures that are performed at the same operative session. Under the Medicare physician fee schedule (MPFS), payments are adjusted to 150 percent of the unilateral payment when a service has a bilateral payment indicator assigned.
Modifiers that can be used with CPT® codes 76641 or 76642 include: 1 50 – Bilateral procedure. This modifier is used to bill bilateral procedures that are performed at the same operative session. Under the Medicare physician fee schedule (MPFS), payments are adjusted to 150 percent of the unilateral payment when a service has a bilateral payment indicator assigned. 2 26 – Professional component. A physician who performs the interpretation of an ultrasound exam in the hospital outpatient setting may submit a charge for the professional component of the ultrasound service by appending this modifier to the ultrasound code. 3 TC – Technical component. This modifier is used to bill for services by the owner of the equipment to report the technical component of the service. This modifier is commonly used when the service is performed in an independent diagnostic testing facility (IDTF).
When mammography reveals an abnormal finding, a breast ultrasound may be used during a needle biopsy or as a follow-up test. A breast ultrasound alone is not considered a good breast cancer screening tool.
Submit the appropriate ICD-10 diagnosis code that reflects a member’s history of bilateral mastectomy, Z90.13.
This measure evaluates preventive screening only. Biopsies, breast ultrasounds or MRIs are not acceptable .